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OligodendrocytesOligodendrocytes are neuroglial cells responsible, within the central nervous system, for myelin sheath forma-
tion that provides an electric insulation of axons and accelerate the transmission of electrical signals. In order
to be able to produce myelin, oligodendrocytes progress through a series of differentiation steps from oligoden-
drocyte precursor cells to mature oligodendrocytes (migration, increase in morphologic complexity and expres-
sion pattern of speciﬁc markers), which are modulated by cross talk with other nerve cells. If during the
developmental stage any of these mechanisms is affected by toxic or external stimuli it may result into impaired
myelination leading to neurological deﬁcits. Such being the case, several approaches have been developed to
evaluate how oligodendrocyte development andmyelinationmay be impaired. The present review aims to sum-
marize changes that oligodendrocytes suffer from precursor cells tomature ones, and to describe and discuss the
different in vitromodels used to evaluate not only oligodendrocyte development (proliferation,migration, differ-
entiation and ability to myelinate), but also their interaction with neurons and other glial cells. First we discuss
the temporal oligodendrocyte lineage progression, highlighting the differences between human and rodent, usu-
ally used as tissue supply for in vitro cultures. Second we describe how to perform and characterize the different
in vitro cultures, as well as the methodologies to evaluate oligodendrocyte functionality in each culture system,
discussing their advantages and disadvantages. Finally, we brieﬂy discuss the current status of in vivomodels for
oligodendrocyte development and myelination.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Oligodendrocytes (OL) are the myelinating cells of the central
nervous system (CNS). To properly myelinate, OL have to extend
many processes that will contact and envelope a stretch of axon. Thus,
the progression along the oligodendroglial lineage occurs through a
highly regulated program of migration, proliferation, differentiation
and myelination. In addition, OL have a high metabolic rate in order to
assure myelination. Some studies pointed out that during myelination
peak, OL produce three times their weight in myelin and up to 100ys in vitro; DMEM, Dulbecco's
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Gama Pinto, 1649-003 Lisbon,times their weight in support membrane per day [1–3]. These features
turn OL into cells highly vulnerable to several damage pathways. To
evaluate what is involved in OL development and myelination, the
cross talk between these and other nerve cells, or their response to
toxic or external stimulus, several approaches can be used. Moreover,
the ideal features of a cell culture system for in vitro investigation de-
pend onwhat questions the systemmust address. Here,we ﬁrst address
the current view of OL lineage progression, comparing the temporal
OL development and myelination in humans vs. rodents. Then, we de-
scribe different methodologies to evaluate changes in OL proliferation,
migration, differentiation and myelination using pure, co-culture and
organotypic slice systems, discussing the advantages and disadvantages
of each model. Finally, we compare the use of these in vitro systems
with current in vivo models.
2. Oligodendrocyte lineage progression
During OL development, differentiation steps can be identiﬁed
according to their migratory capacity, the dramatic increase in morpho-
logic complexity and the expression pattern of speciﬁc markers. During
maturation, oligodendroglial cells acquire an elaboratemorphology and
lose their capacity to proliferate and migrate. The majority of authors
1918 A. Barateiro, A. Fernandes / Biochimica et Biophysica Acta 1843 (2014) 1917–1929divide OL maturation stages into four different steps: oligodendrocyte
precursor cells (OPC), preoligodendrocytes (or late OPC), immature
(or pre-myelinating) OL and mature (or myelinating) OL (Fig. 1). OPC
are proliferative cells, with great migratory capacity and speciﬁc
expression of platelet-derived growth factor receptor α (PDGF-Rα),
ganglioside A2B5, proteoglycan NG2 [4,5], polysialic acid-neural cell
adhesion molecule [6] and fatty-acid-binding protein (FABP)7 [7].
Although NG2+ progenitors show slightly different morphologies de-
pending on their location in the brain, they are usually characterized
by a small polygonal soma and a multipolar tree of ﬁne processes
[8–10]. However, some studies demonstrated that NG2 cells in white
matter have a bipolar morphology characteristic of neural precursor
cells, with only a few processes that are short in length and emanate
from the opposing poles of the cell body [11]. During the differentiation
process, OPC give rise to preoligodendrocytes that extend multipolar
short processes and start to express OPCmarkers aswell as the sulfatide
recognized by the O4 antibody [12] and the GPR17 protein [13], which
persist until the immature OL stage. Upon loss of A2B5 and NG2
markers, immature OL continue to express O4 and begin to express
galactocerebroside C [14]. At this point, OL become post-mitotic cells
with long ramiﬁed branches and are committed to the oligodendroglial
lineage [15,16]. In the ﬁnal stages of OL development, mature OL extend
membranes that form compact enwrapping sheaths around the axons
and express, in an orderly manner, myelin proteins (e.g. myelin basic
protein [MBP], proteolipid protein, myelin associated glycoprotein,
and ﬁnally myelin oligodendrocyte glycoprotein) [17–19]. Moreover,
mature OL also express markers such as MRF/Gm98 [20], zinc ﬁnger
protein 488 [21] and FABP5 [7].
2.1. Temporal oligodendrocyte development andmyelination— humans vs.
rodents
While the proliferation and migration of neurons occur mainly dur-
ing the prenatal period, the proliferation and migration of glial cells are
essentially postnatal processes, with differentiation and maturationFig. 1. Four steps of oligodendrocyte maturation toward oligodendroglial lineage: oligoden
oligodendrocytes. These stages are identiﬁable according to their increasingly complexmorphol
and differentiate. CNPase, 2′,3′-cyclic nucleotide 3′-phosphodiesterase; FABP, fatty-acid-bindin
basic protein; MOG, myelin oligodendrocyte glycoprotein; MRF, myelin gene regulatory factor
acid-neural cell adhesion molecule; zfp, zinc ﬁnger proteins.taking place throughout childhood. Given these overlapping situations
there are several doubts about the temporal extent of each glial cell
process during the postnatal period in humans, as well as their
intermingled phases.
In humans, only a few studies have assessed the temporal OL
development. Four successive OL stages: OPC, preoligodendrocytes,
immature OL and mature OL were characterized between 10 and 41
gestational weeks. The ﬁrst OPC are observed in the forebrain at
10 weeks, higher numbers of OPC are appearing only around
15 weeks, namely in the ganglionic eminences and in the cortical
ventricular zone/subventricular zone [22]. Between 18 and 28 weeks,
OPC and preoligodendrocytes, identiﬁed by NG2 staining, are the most
relevant OL stages in parallel with a minor population of immature OL.
Between 28 and 40 weeks, a wave of OL differentiation within the
periventricular whitematter is accompanied by an increase in the num-
ber of immature OL and in MBP+ myelin sheaths [23,24]. Around
30 weeks of gestation, a marked increase in O4+ cells displaying a
complex multipolar morphology are observed mostly in deeper and
milder cerebral white matter, being sparsely distributed in the superﬁ-
cial white matter and not detected in cerebral cortex. The ﬁrst MBP+
cells are observed between 20 and 28 weeks in subcortical regions,
but are only extensively visualized between 36 and 40 weeks, with an
increase of myelinated white matter from 1 to 5% of total brain volume
[23,25].
In rodents, both rat and mouse present the ﬁrst wave of OPC
around embryonic day (E) 9.5 at the telencephalon, namely in the
entopeduncular area [26]. Accordingly, it was shown that in E13
mouse, ventral telencephalic regions have a greater capacity to generate
OL in vitro than in the corresponding cortical regions [27]. At postnatal
day (P)2, both rat and mouse display preoligodendrocytes as the major
OL stage in the cerebral white matter with a minor population of
immature OL. At P7, the white matter contains more than 80%
immature OL that begin to initiate myelination [28].
In comparison (Fig. 2), OL lineage progression in cerebralwhitemat-
ter occurs similarly in P2 rodents and around 18–27 weeks of gestationdrocyte progenitor cells, preoligodendrocytes, immature oligodendrocytes and mature
ogy, the expression pattern ofwell-deﬁnedmarkers and their ability to proliferate,migrate
g proteins; GalC, galactocerebroside C; MAG, myelin associated glycoprotein; MBP, myelin
, PDGF-Rα, platelet-derived growth factor; PLP, proteolipid protein; PSA-NCAM, polysialic
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immature OL. Later at P7, the white matter from rodents presents a
state of maturation similar to the one observed in humans between
30–36 weeks [24]. Finally, the ﬁrst MBP+ cells are observed around
P7 in rodents, becoming increasingly abundant at P14, both in rat and
mouse brains [29–31], similar to the extent of myelination in many
full-term infants [23].
Concerningmyelination, it typically proceeds in a posterior to rostral
direction [32]. Some degree of myelination is observed prenatally in
humans, so that the peripheral nerves, the pons and the cerebellar pe-
duncles are fairly well myelinated at birth [33]. At 6 months, the genu
of corpus callosum is myelinated and, thereafter, between 8 and 12
months, myelination takes place in frontal, parietal and occipital lobes
[34]. The volume of white matter increases progressively by approxi-
mately 12% from 4 to 22 years of age, and in the prefrontal cortex
myelination is completed only in adolescence/early adulthood [35]. In
comparison, some studies have revealed that rat myelination appears
to begin in the caudal/brainstem regions and to proceed to the fore-
brain, involving medial regions before the lateral ones, as in humans
[32].3. In vitro models to evaluate oligodendrocyte development and
myelination
The development of amethod to growOPC frommixed glial cultures
[36] has allowed the evaluation of biological processes andmechanisms
of cell death in OPC, as well as the mechanisms underlying their differ-
entiation into myelinating OL. However, this in vitro model does not
allow the communication between OL and neurons, which is essential
for proper myelination. In this context, the co-culture system is very
useful, as it allows the maintenance of OL-neuron interaction in the
absence of possible confounding effects of other nerve cells. In addition,Fig. 2. Comparison between oligodendrocyte lineage development in humans and
rodents. Oligodendrocyte precursor cells (OPC), identiﬁed byNG2 staining, appear around
embryonic day (E)9 in rodents and between 10 and 18 gestational weeks (g.w.) in
humans. Oligodendrocyte lineage at postnatal day (P)2 in rodents is similar to that in
humans between 18 and 28 g.w. and is composedmainly of OPC and preoligodendrocytes,
with a minor population of immature oligodendrocytes (O4+ cells). White matter at P7
rodents is similar to that observed in humans between28 and 40 g.w., with predominance
of immature oligodendrocytes and a progressive increase inmature oligodendrocytes that
express the myelin basic protein (MBP).to evaluate OL development and myelination in conditions very similar
to their original environment, ex vivo organotypic slice cultures should
be used, since this model preserves the three-dimensional architectural
organization that supports cell–cell and cell–matrix interactions.
3.1. Oligodendrocyte proliferation model
3.1.1. Oligodendrocyte precursor cells isolation and culture
Primary OPC cultures are isolated from P1 to P2 neonatal rat cortices
as previously described by Chen and collaborators [37] with our minor
modiﬁcations [38] as described in Fig. 3A. In brief, after decapitation
the rat brain is collected in Dulbecco's Modiﬁed Eagle's Medium
(DMEM) (Biochrom AG, Berlin, Germany) and meninges, blood vessels
and white matter are removed. After that, cells can be dissociated by
mechanical or chemical treatment. For mechanical dissociation, the
cortex is homogenized by mechanical fragmentation and the cell sus-
pension passed sequentially through steel screen of 230 and 104 μm
pore sizes. For chemical dissociation, cells are incubated with papain
(3 U/mL, Worthington, Lakewood, NJ, USA), L-cysteine (0.24 mg/mL,
Sigma Chemical Co., St. Louis, MO, USA) and DNase (40 μg/mL, Sigma)
for 60 min at 37 °C, and then DMEM containing 10% fetal bovine
serum (FBS, Biochrom AG) is added to quench the enzyme action.
After cellular dissociation, OPC can be isolated by different methods,
like shake-off and cell sorting.
First, themost widely used and inexpensivemethod to isolate OPC is
the shake-off technique (Fig. 3A). Using this approach, dissociated cells
are collected by centrifugation at 300 g for 10 min and resuspended in
DMEM supplementedwith 20% FBS, 1 mM sodium pyruvate (Biochrom
AG), 2 mM L-glutamine (Biochrom AG) and 0.5% antibiotic antimycotic
(Sigma). Finally, 4 × 105 cells/cm2 are plated on tissue culture ﬂasks and
maintained at 37 °C in a humidiﬁed atmosphere of 5% CO2. Culture
medium is replaced after 2 days in vitro (DIV) and every 2 days thereaf-
ter. After 10 DIV, microglia present on the top of conﬂuent mixed glial
cultures are detached by shaking for 1 h at 200 r.p.m. using an orbital
shaker. After medium removal, new fresh culture medium is added,
and OL at the top of the astrocyte monolayer are detached by shaking
for 24 h at 300 r.p.m. Contamination from other glial cells can be
removed through ﬁltration with a 30 μm nylon mesh or by differential
adhesion in uncoated bacterial dishes during 15 min at 37 °C.
Another emerging method of OPC isolation is magnetic-activated
cell sorting (MACS) that allows OPC separation immediately after
brain dissociation [39]. After centrifugation, dissociated brain cells are
counted and rat anti-mouse IgMmagnetic beads in 10% v/vMACS buffer
are added to cells to facilitate the removal of cellular debris and dead
cells. After 15 min at 4 °C with gentle shaking, cells are resuspended
in 5 mL MACS buffer and centrifuged for 5 min. During centrifugation, a
MACS column is stepped up on a MACS magnetic stand and equilibrated
with 0.5 mL of MACS buffer. After centrifugation, cells are resuspended
in 0.5 mL MACS buffer, transferred to the column, and the column is
washed four times with 0.5 mL MACS buffer. The initial wash ﬂow
through and all subsequent ones are collected in a single tube and cen-
trifuged for 5 min. At this point, bound cell debris and dead cells that re-
main in the column are discarded. Following centrifugation, the pellet is
resuspended in 400 μL of diluted O4 antibody (20% v/v in MACS buffer)
and incubated 10 min at 4 °C with gentle shaking. Then, the cell suspen-
sion is washed two times with 5 mL MACS buffer and centrifuged for
5 min. Taking into account that for every 1 × 107 cells, 20 μL MACS
beads are mixed with 180 μL MACS buffer, cells are resuspended in an
appropriate volume of this mixture, incubated 15min at 4 °C with gen-
tle shaking and centrifuged for 5 min. During centrifugation, another
MACS column is equilibrated with 0.5 mL MACS buffer as described
before. The pellet is resuspended in 0.5 mL MACS buffer, added to the
column and washed four times with 0.5 mL MACS buffer. The column
is then removed from the magnet and by positioning above a new
tube, bound cells are eluted in 1 mL MACS buffer. A fresh column is
quickly equilibrated, the eluted cells added and washed four times
Fig. 3. Key steps of oligodendrocyte proliferationmodel and demonstration of possible evaluations. (A) Oligodendrocyte precursor cells (OPC) are isolated from P1 to P2 neonatal rat cor-
tices, cultured inmixed glial culture medium andmaintained in culture until 10 days in vitro (DIV). Culture medium is replaced after 2 DIV and every 2 days thereafter. After 10 DIV, ﬁrst
microglia are detached by 1 h shaking and after oligodendrocytes are detached by 24 h shaking. After isolation, oligodendrocytes are plated in oligodendrocyte precursor cell (OPC)
medium and maintained in culture for 6 DIV. At this point, medium is changed every 2 days and at 6 DIV an enriched OPC culture is observed. (B) This culture is constituted mainly by
cells with bipolar morphology that express NG2 (84.5%) and a minor fraction is oligodendrocytes in a back stage positive for nestin (4.3%) and preoligodendrocytes positive for A2B5
(10.6%). Only a few cells (0.6%) are astrocytes that stain for glial ﬁbrillary acidic protein (GFAP). Scale bar represents 50 μm. (C) In this model it is possible to incubate OPC with different
compounds, like unconjugated bilirubin (UCB), to evaluate and compare changes in OPC viability by TUNEL assay or propidium iodide (PI) ormechanisms underlyingOPC demise. Byﬂuo-
rescence it is possible to evaluate individual cell production of reactive oxygen species (ROS) using dihydrorodamine 123 (DHR) dye ormitochondrial dysfunction usingMitotracker®Red
dye. Graph bars represent the quantiﬁcation of apoptosis, necrosis-like cell death, ROS production andmitochondrial dysfunction after UCB treatment. Scale bars represent 20 μm. DMEM,
Dulbecco'sModiﬁed Eagle's Medium; FBS, fetal bovine serum; FGF-2, ﬁbroblast growth factor 2; GFAP, glial ﬁbrillary acidic protein; PDGF-AA, platelet derived growth factor AA. **P b 0.01
vs. vehicle-treated cells. Adapted from [38].
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with 1mL OPCmedium [DMEM, L-glutamine (4mM), sodium pyruvate
(1mM), bovine serumalbumin (0.1%, Sigma), apo-transferrin (50 μg/ml,
Sigma), insulin (5 μg/ml, Sigma), sodium selenite (30 nM, Sigma),
D-biotin (10 nM. Sigma), hydrocortisone (10 nM, Sigma)] containinghuman platelet-derived growth factor (PDGF)-AA (30 ng/mL, PeproTech,
RockyHill, NJ, USA) and basicﬁbroblast growth factor (FGF)-2 (30 ng/mL,
PeproTech).
After both types of isolation, the ﬁnal cell suspension is plated
at 6 × 104 cell/cm2 on tissue culture plates and maintained in OPC
1921A. Barateiro, A. Fernandes / Biochimica et Biophysica Acta 1843 (2014) 1917–1929medium containing PDGF-AA and FGF-2 to stimulate proliferation
and inhibit differentiation. Medium is changed every 2 days and after
6 DIV an enriched OPC culture is obtained.
As shown in Fig. 3B, the majority of the cells present bipolar
morphology and express NG2 (84.5%). A minor fraction is OL in a back
stage positive for the precursor marker nestin (4.3%) and others are
preoligodendrocytes positive for A2B5 (10.6%). Some cells simulta-
neously stain for NG2 and nestin (cells in a far premature phase)
(45.7%), while others stain for NG2 and A2B5 (cells in a rather margin-
ally advanced stage of differentiation thanOPC) (38.6%). Only a few cells
(0.6%) are glial ﬁbrillary acidic protein (GFAP) positive with typical as-
trocyticmorphology and stain independently of OPC. NoMBP or ionized
calcium binding adaptor molecule 1 (Iba-1) positive cells are observed,
indicating that mature OL andmicroglia, respectively, are absent in this
OPC culture model.
3.1.2. Oligodendrocyte precursor cell viability and functionality assays
This in vitro model of proliferating OPC is useful to evaluate: (i) how
certain stimuli can directly disturb the process of OPC proliferation and
their survival; and (ii) to clarify the mechanisms underlying OPC de-
mise. In the current review, we present data obtained from our recent
studies concerning the role of unconjugated bilirubin (UCB) onOPC sur-
vival, differentiation and OL myelination [38,40,41]. To evaluate the ef-
fect of UCB in OPC survival, at 6 DIV OPC cultures were incubated with
50 μM UCB (Sigma) for 6 h to mimic clinically relevant conditions of
jaundice as described [38]. At the end of UCB incubation, adherent
OPC cultured on coverslips were rinsed with DMEM and incubated
with 75 μM propidium iodide (Sigma) fresh solution to evaluate
necrosis-like cell death, or with 50 nM Mitotracker red (Molecular
Probes, Eugene, OR, USA) to determine changes inmitochondrial viabil-
ity. Additionally, another set of OPC was ﬁxed with 4% (w/v) parafor-
maldehyde in phosphate-buffered saline (PBS, pH 7.4) to evaluate
apoptosis-like cell death using TUNEL assay (RocheMolecular Biochem-
icals, Mannheim, Germany). To evaluate the production of reactive oxy-
gen species (ROS), OPC were incubated with dihydrorhodamine 123
(Sigma) prior to UCB treatment. This non-ﬂuorescent molecule easily
crosses cell membranes and is converted by intracellular generated
ROS into rhodamine 123, a ﬂuorescent compound that accumulates in
mitochondria. As shown in Fig. 3C, treatment with UCB reduced OPC
survival either through apoptosis and necrosis-like cell death, involving
individual cell mitochondria damage and ROS production. In addition to
the methodologies described here, it is also possible to collect cell ly-
sates and evaluate any alterations of the intracellular proteins involved
in these or other pathways using Western blot [38]. However, it is
known that other glial cells and neurons play an important role on
OPC maintenance. To overcome this issue, it is possible to explore the
effect of released factors by other nerve cells on OPC survival and prolif-
eration, if we incubate OPC with conditionedmedium from another cell
type [42,43] and evaluate the same parameters described above.
3.1.3. Oligodendrocyte precursor cell migration assays
After OPC isolation, their migration can be assayed by different tech-
niques that include Boyden chamber migration assay, agarose drop
assay and scratch assay (Fig. 4).
The Boyden chambermigration assay (Fig. 4A) is used to evaluate di-
rect migration of OPC in the presence of chemotactic and haptotactic
stimuli [44,45]. In this method, OPC migrate through pores from an
upper surface, where cells are plated, to a lower chamber containing ei-
ther a soluble chemoattractant or a coated lower surface (haptotactic
gradient). In this context, isolated OPC are resuspended in DMEM and
then 5 × 104 cells in 50 μL of DMEM containing 0.5% FBS are seeded in
the upper compartment of the Boyden chamber containing an 8 μm di-
ameter polycarbonate membrane with polyvinylpyrrolidone surface
treatment. In chemotactic assays, only the medium in the bottom well
contains the chemoattractant (directed migration of cells toward
regions of higher concentrations), whereas in chemokinetic assays thechemoattractant is added to both lower and upperwells of the chamber,
thereby eliminating a chemical gradient (stimulation of increased ran-
dom cell motility). Commonly used OPC chemoattractants are PDGF
and FGF [45,46]. In haptotactic assays, no chemoattractants are added,
but the lower surface of the membrane and the pores are coated with
known matrix substrates (i.e., laminin, ﬁbronectin). To assay the role
of a speciﬁc stimulus on OPC migration, the studied molecules are
added to the upper well chamber and OPC allowed to migrate for 6 h
to 24 h at 37 °C in 5% CO2. Membranes are removed from the Boyden
chamber, ﬁxed and non-migrated cells from the upper surface of the
membrane are discharged by gentle scraping and rinsing. Remaining
migratory cells are stained with Giemsa and the number of migrated
cells counted. As an example, to assay the role of UCB on OPCmigration,
cells were plated in the upper compartment of the Boyden chamber in
the presence of either 50 μM UCB (chemotaxis) or UCB plus 10 ng/mL
FGF (chemokinesis) and allowed to migrate for 24 h to the lower com-
partment containing FGF (10 ng/mL). As shown in Fig. 4D, both OPC
chemokinesis and chemotaxis were remarkably reduced following
UCB treatment, the chemotaxis being the most affected one. As advan-
tages, this is a quick assay, with signiﬁcant migration often being seen
within a short time period. Moreover, as the volume required for each
well is very small, the cost of experiments involving growth factors or
blockingmolecules is reducedwhen comparedwith othermigration as-
says. Although counting the migrated cells is labor-intensivemethodol-
ogy, it is a precise and objective method. Themajor disadvantage of this
method is the need for a large number of cells, which may represent
problems when primary cultures are being used.
In agarose drop assay [46], OPCmigration froma small drop is driven
by the high concentration of cells in the agarose drop and the innate
motility of cells (Fig. 4B), allowing the evaluation of chemokinesis or
random migration in the presence of different stimuli. In order to per-
form this assay, isolated OPC are resuspended at a density of 5 × 107
cells/mL in Sato media [4 mM L-glutamine, 16 μg/mL putrescine
(Sigma), 400 μg/mL triiodothyronine (Sigma), 400 μg/mL thyroxine,
6.2 ng/mL progesterone (Sigma), 5 ng/mL sodium selenite, 100 μg/mL
bovine serum albumin, 5 μg/mL insulin, 50 μg/mL holo-transferrin
(Sigma) in DMEM] supplemented with 10% FBS and 0.3% low-melting
point agarose maintained at 37 °C to prevent hardening. Then 1.5 μL
drops of this suspension are plated at the center of coated wells (24-
well tissue culture plate) andmaintained at 4 °C for 15min for the hard-
ening of agarose. After cooling, 50 μL SATO medium is carefully added
around the drop and 2 h after, the remaining 450 μl is added down
the side of the well. The agent of interest can be added immediately
with themediumor 24 h later, in order to evaluate its role onOPC ability
to exit from the agarose drop or to migrate, respectively. Cell migration
is measured daily for 1 to 6 DIV using a phase contrast microscope with
calibrated graticule. Cells migrate out to form a uniform corona around
the drop and the distance between the edge of the drop and the leading
edge ofmigrating cellswithin the corona ismeasured. The results can be
expressed as a distribution curve by measuring the number of cells at
different distances from the edge of the agarose drop. In this assay, as
cells are maintained in culture for several days aphidicolin (20 μl/mL),
which inhibits DNA replication, can be added to the SATOmedia to pre-
vent proliferation [47]. As advantages, this assay allows the evaluation
of cell migration extension at more time-points without compromising
the culture viability. Moreover, it enables the introduction and the re-
moval of inhibitors or blocking antibodies after the start of the assay,
thus allowing the reversible nature of blocking agents. Finally,migrating
OLmorphology on different substrates or under different conditions can
also be evaluated. The major disadvantage of agarose drop assay is that
it takes several days and during this timeOLmay synthesize and secreat
other factors in addition to the factor of interest that can inﬂuence
migration.
Finally, the in vitro scratch assay is based on the creation of an
artiﬁcial gap on a conﬂuent cell monolayer, so called “scratch”, and
subsequent polarization and migration of the cells on the edge of the
Fig. 4. Different assays to evaluate OPC migration and demonstration of possible evaluations. (A) In the Boyden chamber migration assay, oligodendrocyte precursor cells (OPC) migrate
throughpores, during 6–24h, from theupper chamber,whereOPC are plated, to a lower chamber. In chemotaxis assays, only themedium in the bottomwell contains the chemoattractant,
whereas in chemokinetic assays the chemoattractant is added to both lower and upper wells of the chamber, thereby eliminating a chemical gradient. (B) In the agarose drop assay, OPC
migrate away from a small drop containing a high concentration of cells. Cell migration is measured until 6 days in vitro (DIV) using a phase contrast microscope. (C) The scratch assay
consists of the creation of an artiﬁcial gap on a conﬂuent OPC monolayer and subsequent OPC migration at the edge of the gap to close the “scratch”. (D) Graph bars represent OPC
migration using the Boyden chamber assay in conditions of chemotaxis and chemokinesis in the presence or absence of UCB. *P b 0.05 and **P b 0.01 vs. vehicle-treated cells.
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plated as described in Section 3.1.1. When OPC reach 70–80% conﬂu-
ence, a wound is made across the cells with a cell scraper. Then cultures
are washed with DMEM and kept with SATO medium without growth
factors and supplemented with the agent of interest. OPC are allowed
tomigrate for 24–48 h and the number of OPC thatmoved across the in-
jury line is counted using a phase contrast microscope. Scratch assay is
still a method of choice to analyze cell migration, because it is a simple
and inexpensive technique and all the required materials are usual
labware, also the experimental conditions can be easily modiﬁed for
different purposes. Moreover, this assay allows the observation of
migrating OL morphology and is particularly suitable to evaluate the
regulation of cell migration by interaction with extracellular matrix or
other cells, since there is no need to isolate OPC and as a consequence
disrupt such interactions. Finally, scratch assay is also compatible with
live cell imaging allowing the analysis of intracellular signaling events.
However, thismethod does not replace other well-establishedmethods
for chemotaxis, like Boyden chamber assay, as no chemical gradient is
established. It is also a relatively time-consuming assaywhen compared
with other methods, since several days (i.e. 10–15 DIV) are needed for
the establishment of cell monolayer and then around 24–48 h for cellmigration to close the “scratch”. Another disadvantage is the relatively
large amount of cells and chemicals needed for the assay as it is usually
performed in a tissue culture plate.
3.2. Oligodendrocyte differentiation model
3.2.1. Oligodendrocyte differentiation culture
Primary OPC are isolated as described in Section 3.1.1 and further
cultured for differentiation as described by Syed [48] with our
minor modiﬁcations [40]. Puriﬁed OPC are plated at a density of
2.5 × 104 cells/cm2 in SATO media supplemented with 1% penicillin/
streptomycin, 1% insulin-transferrin-sodium selenite (ITS, Sigma),
0.5% FBS, 10 ng/mL PDGF-AA and 10 ng/mL FGF-2 in order to promote
OL adherence in a pro-survival and proliferative environment. After
1 DIV, differentiation is induced by replacing PDGF-AA and FGF-2 by
3% FBS in SATO medium and cells are kept in culture in order to obtain
an enriched culture of mature OL (Fig. 5A). In this system, and without
the presence of axons, OPC are able to differentiate and synthesize
membrane sheets whose organization is very similar to that of myelin.
After 7 DIV, cells in culture are mainly mature OL that express MBP
(87.0%) and a minor fraction is NG2+ OPC.
Fig. 5.Key steps of oligodendrocyte differentiationmodel and demonstration of possible evaluations. (A) Oligodendrocytes (OL) are isolated fromP1 to P2 neonatal rat cortices, cultured in
mixed glial culture medium and maintained in culture until 10 days in vitro (DIV). Culture medium is replaced after 2 DIV and every 2 days thereafter. After 10 DIV, ﬁrst microglia are
detached by 1 h shaking and after OL are detached by 24 h shaking. After isolation, OL are plated in proliferationmediumduring 24 h and at this pointmedium is changed to differentiation
medium and OL are kept in culture. After 18 DIV is observed an enriched mature oligodendrocyte culture, constituted mainly by mature OL that express myelin basic protein (MBP) and
only few cells are oligodendrocyte progenitor cells that stainwith NG2. (B) Using thismodel of OL culture is possible to evaluate changes in OL differentiation stages. Graph bars represent
the quantiﬁcation of immature OL (NG2+ staining, red) andmature OL (MBP+ staining, green) from vehicle- and UCB-treated cells at 18 DIV. (C) In thismodel it is also possible to eval-
uate changes in OLmorphology through the division ofmature OL in different stages ofmorphologic maturity like: (1) OLwith poorly branched processes, (2) OLwith complex branched
processes and (3) OL that partially formmembranes. Graph bars represent the quantiﬁcation of OL in these different stages after 18 DIV in the presence or absence of UCB. (D) As dem-
onstrated in this type of culture it is also possible to isolate a single OL in order to perform Sholl analysis and evaluate changes in OL process branching in vehicle- and UCB-treated cells.
Scale bar represents 50 μm.DMEM, Dulbecco'sModiﬁed Eagle'sMedium; FBS, fetal bovine serum; FGF-2, ﬁbroblast growth factor 2; PDGF-AA, platelet derived growth factor AA. **P b 0.01
vs. vehicle-treated cells. Adapted from [40].
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Using this model of OL differentiation, it is possible to evaluate if any
compound added during the proliferation or the differentiation stages is
able to delay or reduceOL differentiation by analyzingﬁrst the number of
OPC (NG2+ staining) and mature OL (MBP+ staining). As an example,to evaluate if UCB treatment during the proliferation stage affects
OL maturation, OPC cultures were incubated with 50 μM UCB during
the ﬁrst 24 h after OPC isolation, and kept in culture in SATO medium
until 7 DIV [40]. As shown in Fig. 5B, UCB reduced OPC differentiation
in MBP+ cells. Moreover, the present model allows the evaluation of
1924 A. Barateiro, A. Fernandes / Biochimica et Biophysica Acta 1843 (2014) 1917–1929whether certain molecules may also affect OL characteristic morpholog-
ical changes during maturation. Indeed, it is possible to categorize the
morphology of MBP+ mature OL in several stages of maturation such
as: 1) OLwith poorly branched processes; 2) OL with complex branched
processes; and 3) OL with complex morphology that partially form
membranes (Fig. 5C). In the absence of treatment (vehicle-treated
cells), most of the mature OL is in stage 2 (71.0%), some in stage 1
(21.6%) and only a few in stage 3 (7.4%). On the other hand, UCB treat-
ment delayed OL morphological maturation presenting an increased
number of stage 1 OL (38.7%) [40]. If an increased population of mature
OL in stage 3 is desired, the differentiating OL culture must be kept in
culture for more days.
In this type of culture, it is also possible to measure OL diameter and
process complexity using Sholl analysis. To perform Sholl analysis, ﬁrst
principal OL processes are outlined using NeuronJ plugin for ImageJ
(National Institutes of Health, USA) to exclude adjacent cells and sec-
ondary processes. Next, a minimum of 50 MBP+ cells are measured
for the number of intersections made by branching processes with
each successive circle using Sholl analysis plugin for ImageJ. In Fig. 5D,
vehicle- and UCB-treated cells are shown in a grid of 8 concentric circles
with increasing radius superimposed on OL cell body (starting radius,
10 μm; step size, 10 μm; end, 80 μm) and respective graph with the
quantiﬁcation of the number of intersections of primary processes per
radius of Sholl ring. Vehicle-treated cells present a total diameter of
around 70 μm and a maximum number of intersections from primary
processes at 12–20 μm, while UCB-treated cells show a reduced diame-
ter (b60 μm) and reduced extension of maximum intersections from
primary processes (8–16 μm) [40].
These morphological maturation alterations observed in OL
branching andmembrane formation can be directly relatedwith chang-
es in the activity of Rho family GTPases that have been described as
regulators of cytoskeletal structure [49,50]. Small GTPases of the Rho
family, like cdc42, Rac1 and RhoA, are signalingmolecules that regulate
the organization of the actin cytoskeleton, microtubule dynamics, cell
polarity andmembrane trafﬁcking in response to environmental signals
[51]. In the CNS, active Rac1 and Cdc42 act as positive regulators ofmor-
phological differentiation, inducing process extension and branching,
while RhoA acts as a negative regulator to inhibit the process of elonga-
tion [52].
Although in these pure OPC/OL culture systems we can identify the
OL-speciﬁc effect of a certain stimulus in their differentiation and the
mechanisms involved, this type of culture does not allow the analysis
of signaling interactions between OL and neurons which are crucial for
the myelination event.
3.3. Myelinating co-culture model
3.3.1. Oligodendrocyte-neuron co-culture
In order to preserve the physiological relevance of OL-neuron inter-
actions and maintain the accessibility of in vitro cell culture models,
usually OL-neuron co-culture system is used, that allows the study of
myelination without confounding effects exerted by other nerve cell
types. Here, we describe the co-culture model that comprises dorsal
root ganglion (DRG) neurons cultured on growth factor-reduced 3D
Matrigel (BD Biosciences, Erembodegem, Belgium) and OL from the
CNS (Fig. 6A). This culture system is described according to the method
reported by Laursen et al. [53] with our minor modiﬁcations [40]. DRG
neurons are obtained from E15 rats and dissociated with papain
(1.2 U/mL), L-cysteine (0.24 mg/mL) and DNase (40 μg/mL) for 60
min at 37 °C. After dissociation, DMEM with 10% FBS is added in order
to stop enzyme action and cells are collected by centrifugation at 200
g for 5 min. Finally, 150 μL of cell suspension at a density of 1.5 × 105
cells are plated on a 18 mm coverslip coated with poly-D-lysine and
growth factor-reduced Matrigel, and cultured for 21 DIV in DMEM sup-
plemented with 10% FBS, 1% penicillin/streptomycin and 100 ng/mL
nerve growth factor (Serotec, Raleigh, NC, USA). In order to removecontaminating cells, the culture is pulsed three times for 48 h with 5-
ﬂuoro-2′-deoxyuridine (20 μg/mL, Sigma) at 1, 4 and 7 DIV after
seeding. Culture media are changed every 2 days and after 21 DIV the
medium is replaced by basal media Eagle (Gibco, Life Technologies,
Inc., Grand Islands, USA) with 1% ITS, 1% penicillin/streptomycin, 1%
glutamax (Gibco), 1% glucose (Sigma) and 0.5% FBS. At this time,
puriﬁed OPC are seeded onto the neurons at a density of 7.5 × 104 per
coverslip. Co-cultures are maintained for 15 DIV with media changed
every 2–3 DIV.
In this system,myelination starts 6 DIV after the addition of OPC and
it is possible to observe the formation of the ﬁrstmyelin sheaths around
9 DIV. At 14 DIV, after OPC addition, 36 DIV for global culture, the ma-
jority of OPC has diffentiated into mature OL and extensive myelination
has occurred. The relationship between neurite density and the
percentage of OL forming myelin sheaths provides a robust basis for
myelination analysis.
3.3.2. Oligodendrocyte differentiation and myelination analysis
In this model also, it is possible to evaluate changes in OL differenti-
ation stages by staining NG2+ OPC andMBP+mature OL as described
for OL differentiation system. As an example, the co-culture systemwas
treated with 50 μM UCB at 1 DIV, in order to evaluate how UCB may
affect the initiation of myelination as previously reported [40]. As ob-
served in Fig. 6B, at 14 DIV of co-culture vehicle-treated cells show an
increased number of mature MBP expressing OL (57.4%), while UCB-
treated cells show a prevalence of NG2 expressing OPC (60.6%). This
model also allows the evaluation of the myelination stage of mature
OL, categorizing them in three different stages: (1) cells that only
extend processes but do not contact with neuroﬁlaments; (2) cells
that establish contact with neuroﬁlaments but do not myelinate; and
(3) cells that wrap axons and have at least two internodes connected
to the cell body (Fig. 6C). Once again our example shows that in
vehicle-treated cells, the majority of cells are OL wrapping (65.5%) or
contacting with axons (22.2%) and the remaining cells are OL in earlier
phase extending processes (12.0%). However, UCB-treated cells show a
delayedmyelination process with increased number of OL in the earlier
phase only extending processes (33.6%) and a reduced amount of OL
contacting (14.1%) or wrapping (49.8%) the axons. In addition, with
this model of myelination it is also possible to access the number of my-
elinated internodes formed by a single OL and the internode length
(Fig. 6D). Visually an internode is deﬁned as a tube of MBP staining
surrounding an axon. In this co-culture model, after 14 DIV of co-
culture, in vehicle-treated cells each OL is able to myelinate approxi-
mately 8 internodes with a mean length of 59.3 μm, while in UCB-
treated cells one OL myelinated approximately 4 internodes with a
mean length of 34.7 μm.
The myelinating co-culture system described here allows the evalu-
ation of the effect of biomolecules on themyelination process as well as
the communication between neurons and OL without the interference
of other glial cells. The extensive time to obtain this culture, since DRG
neuronsmust be cultured for 3 weeks in order to survive independently
of nerve growth factor, a factor that inhibits myelination [54], and 2
more weeks to see substantial myelination, may be viewed as a disad-
vantage. Nevertheless, this system is a relatively robust and ﬂexible
model that survives up to 8 weeks after the addition of OL and allows
the manipulation of gene expression and signaling in vitro since it
uses distinct cells from different sources. In this context, OL obtained
by different techniques from different CNS regions, different ages or
even from different species can be used in this model because all of
them are going to myelinate the DRG neurons. Since OL and DRG
neurons are ﬁrst cultured separately, as described above, both cell
types can be manipulated independently prior to co-culture. In addi-
tion, DRG neurites in this model extend radially from their somas,
facilitating the observation and analysis of myelination when com-
pared with co-cultures with neurons dissociated from CNS that are
very difﬁcult to analyze due to its reticular distribution [55,56]. In
1925A. Barateiro, A. Fernandes / Biochimica et Biophysica Acta 1843 (2014) 1917–1929other hand, it should be noted that DRG neurons are not real CNS
neurons since their cell bodies are located outside the CNS and pro-
ject into the CNS and peripheral nervous system (PNS). However,Fig. 6. Key steps of myelinating co-culture system and demonstration of possible evaluations. (A
ture during 21 days in vitro (DIV). Cells are cultured in DRG medium and are pulsed with 5-
changed every 2 days and after 21 DIV oligodendrocytes (OL) are added to DRG neurons and
medium changes every 2 DIV. After 36 DIV most OL are MBP+ mature OL and the remaining
possible to evaluate the progression along OL lineage, categorizing them, for example, into imm
resent the quantiﬁcation of both differentiation stages after 36DIV in the absence (vehicle) or pr
maturity in (1) OL extending processes, (2) OL contacting with neuroﬁlaments but not myelina
different stages after 36 DIV in vehicle- andUCB-treated cells. (D)With this approach it is also p
internode length. Graph bars represent the quantiﬁcation of both parameters after 36DIV in veh
Medium; FBS, fetal bovine serum; MBP, myelin basic protein; NF, neuroﬁlaments. **P b 0.01 vsprevious ﬁndings have shownthat myelin internode length in co-
cultures with OL and DRG neurons is very similar to that observed
in mouse frontal cortex [57].) Dorsal root ganglion (DRG) neurons are isolated from spinal cord andmaintained in cul-
ﬂuoro-2′-deoxyuridine (FdU) in order to remove contaminating cells. Culture media are
medium is changed to co-culture medium. Co-cultures are maintained 15 DIV more with
cells are NG2+ oligodendrocyte precursor cells. (B) By using this myelination model it is
ature OL (NG2+ staining, white) and mature OL (MBP+ staining, red). Graph bars rep-
esence of UCB. (C) In thismodel it is possible to categorize OL according theirmorphologic
ting and (3) OLwrapping neuroﬁlaments. Graph bars represent the quantiﬁcation in these
ossible to determine the number ofmyelinated internodes per eachOL and themyelinated
icle- andUCB-treated cells. Scale bar represents 75 μm.DMEM, Dulbecco'sModiﬁedEagle's
. vehicle-treated cells. Adapted from [40].
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Although in vitro cultures are very useful and accessible models,
their main disadvantage resides in the loss of the three-dimensional
structure. As so, with the models described above, it is not possible to
maintain the normal structure as well as all cell–cell and cell–matrix
interactions present in the brain tissue. To overcome this issue, it is pos-
sible to study diverse neurobiological processes using ex vivo brain slice
cultures, which preserve the three-dimensional architectural organiza-
tion that supports all tissue circuits and interactions. Slices are thick
brain sections (250–400 μm) that are grownon semiporousmembranes
and kept at an air–liquid interface, which causes less tissue thinning and
allow much simple maintenance and processing [58,59]. When the
main goal is to evaluate changes in myelination, organotypic cerebellar
slice cultures are usually used,which allow the evaluation of OLmatura-
tion process and myelination in a visually deﬁned region. In fact,
myelination in cerebellum occurs postnatally and cerebellar slice
cultures from early postnatal animals replicate the in vivomyelination
process [60,61]. Moreover, cerebellum presents the largest ﬁber tracts
in the mammalian brain in speciﬁc regions, the white matter tracts
[62], which make it an advantageous and practical model to evaluate
myelination.
3.4.1. Cerebellar organotypic slice culture
To perform this model, parasagittal slices are prepared from P7 rat
cerebellum, according to the interface culture media (Fig. 7A). First,
brains are removed, cerebellum isolated and 400 μm slices cut using a
McIlwain tissue chopper and separated under a magniﬁer. Then four
slices are placed in the upper chamber of each 0.4 μm pore cell culture
insert (BD Falcon, Lincoln Park, NJ, USA) and maintained in tissue
culture plates containing 1mL ofmedium constituted by 50%minimum
essential medium Eagle (Sigma), 25% normal horse serum (Gibco), 25%
Hank's Balanced Salt Solution (Gibco), 6.5 mg/mL D-glucose, 1% L-
glutamine and 0.5% penicillin/streptomycin. Half of medium is changed
every day and cultures are kept for 7 DIV. Since rat P7 cerebellar slices
are not completely myelinated at time of culture, during in vitro main-
tenance, OL differentiation occurs until these cells ﬁll the white matter
of folia and startmyelination. After 7 DIV, the cerebellar slice culture ev-
idences a high degree ofmyelination, based on the signiﬁcant number of
myelin segments aligned with axons. Although this culture starts with
400 μm slices, their thickness reduces with time in culture and present
3 distinct regions in the Z plane that differ in their cellular composition
and appearance: the ﬁrst 1–5 μm (‘top’) is where the majority of the
myelin, axons, OL, OPC and astrocytes reside; the next 6–23 μm (‘mid-
dle’) have the same composition as the ‘top’ layer, however at lesser
amounts; the last 24–30 μm (‘bottom’) is mostly devoid of all cellular
components except microglia, which are also found throughout other
depths of the slice albeit at lower densities. It should be noted that be-
fore any treatment slice cultures should be kept for 3 DIV to allow the
clearance of debris and the stabilization of cerebellar slices. If the goal
is to study the effect of a stimulus on myelin formation the culture
should be treated around 3–4 DIV, before myelination is complete,
and the system analyzed at 7 DIV. If the purpose is to evaluate the effect
of an insult on myelination, or how it can promote demyelination, the
slices must be kept for 21 DIV prior to treatment and then analyzed
after treatment or during the next 14 DIV, where remyelination usually
takes place [63].
3.4.2. Oligodendrocyte differentiation, myelination and glia reactivity
analysis
In this ex vivo model, it is possible to evaluate at 7 DIV the presence
of immature OPC, mature OL and myelination, as well as the number of
glial cells such as microglia and astrocytes. To perform this type of
approach slices are stained for NG2+ immature OL, MBP+ mature OL
and neuroﬁlaments to evaluate myelination, as well as for Iba-1+
microglia and GFAP+ astrocytes. Then the percentage of the areaimmunoreactive for each cell type is measured. Brieﬂy, binary masks
for each staining are deﬁned using the same cut-off intensity threshold
value for each region of interest, which corresponds to each cell immu-
nostained, deﬁned as the minimum intensity due to speciﬁc staining
above background values. Then the percentage of area is measured au-
tomatically using ImageJ software in each cerebellum region. Changes in
the percentage of myelinated ﬁbers may be assessed by measure of the
superposition of neuroﬁlament staining and MBP staining. As an exam-
ple, we evaluated the effect of UCB in the de novo myelination [41]. So,
3 DIV cerebellar slices were incubated with UCB during 8 h to mimic an
acute condition of hyperbilirubinemia. As depicted in Fig. 7B, after
7 DIV, in vehicle-treated slices, the majority of ﬁbers are myelinated
(82.3%), while in UCB-treated slices only 57.6% are co-localized with
MBP+ segments. In addition, vehicle-treated slices also present a
lower area occupied by NG2+ OPC (3.1%) in comparison to UCB-
treated ones (7.1%) (Fig. 7C), corroborating the suitability of this
ex vivo system to evaluate changes in OL differentiation stages. More-
over, we also observed that UCB treatment promotes microgliosis and
astrogliosis as evidenced by an increased area occupied by Iba1+
microglia (from 17.3% to 27.5%, Fig. 7D) and GFAP+ astrocytes (from
30.4% to 40.4%, Fig. 7E), respectively.
This culture system should be usedwhen the purpose of the study is
the evaluation of OL development and myelination in conditions very
similar to their environment, since themodel preserves the tissue archi-
tecture and cell–cell interactions. In particular, cerebellar slice culture
allows the evaluation of changes in OL lineage progression and
myelination, because both OPC and OL are abundant in cerebellum
and a high degree of compact myelin is formed with a speciﬁc pattern
after some time [64]. Indeed, in this speciﬁc type of organotypic culture,
it is possible to follow the complex series of dramaticmorphological and
biochemical changes that happen during OL maturation and evaluate
the effect of biomolecules or potential therapeutic strategies in each
crucial step.
3.5. In vitro vs. in vivo models for oligodendrocyte development and
myelination
The in vitro and ex vivo models described previously are relatively
simple and widely applicable models that have the potential to provide
information about OL development and how they can be adversely af-
fected by toxic agents, or to be used as a ﬁrst approach for therapeutic
screening. However, the spatial and temporal signaling present in
in vivo models is difﬁcult to recreate in vitro, while the response of
the systemic circulation and immune cell inﬁltration often seen in de-
myelinating disorders is impossible to determine in cells/tissue cultured
on a tissue culture plate. So, as in vitro models cannot recreate the
complexity of the in vivo biology, in vivo models will be needed as a
ﬁnal step in pre-clinical studies.
Among the in vivo models, zebraﬁsh are increasingly being used to
investigate myelination, since zebraﬁsh andmammalian OL andmyelin
are homologous. Zebraﬁsh are a very useful model as they present a
rapid development, are easily manipulable and are transparent as
embryos, which facilitates in vivo imaging of myelination. However,
the fast growing of this model makes the timing of screens crucial.
Some authors have already demonstrated that in zebraﬁsh, the myelin
sheath thickness is regulated according to axonal size during larval de-
velopment [65], as it occurs in adult CNS of mammals [66]. Moreover, it
was recently shown that although global myelination in the zebraﬁsh
continues over time, each individual OL onlymakes newmyelin sheaths
during a short period of time following initiation of myelination.
However, besides these studies in zebraﬁsh are useful to understand
myelination, these datamay not be all directly translatable tomammals
since zebraﬁsh have a large Mauthner axon that has no equivalent in
mammals and the protein structure of the myelin sheath is different
(CNS myelin in zebraﬁsh contains myelin protein zero that is only
present in the PNS in mammals).
Fig. 7. Key steps of cerebellar slice culture and demonstration of possible evaluations. (A) Parasagittal slices are prepared from P7 rat cerebellum and kept in culture in cerebellar slice culture
mediumduring 7 days in vitro (DIV). Half ofmedium is changed every day and the ﬁrst 3 DIV allow the clearance of debris and the stabilization of cerebellar slices. After 7 DIVmost of the ﬁbers
aremyelinated. (B)Using cerebellar slice culture it is possible to observe changes inmyelination after UCB treatment, as observed by the superposition (yellow) of theneuroﬁlament (NF, green)
and themyelin basic protein (MBP, red) staining. Graph bars represent the quantiﬁcation of the percentage ofmyelinatedﬁbers in vehicle- andUCB-treated slices after 7DIV. (C) In thismodel it
is also possible to evaluate thepresence of immature oligodendrocytes bymeasuring the percentage of area occupiedbyNG2 staining. In addition, as thismodel preserves the cytoarchitecture of
the tissue it is also possible to evaluate changes inmicroglia and astrocyte reactivity through the determination of thepercentage of area occupied by ionized calciumbinding adaptormolecule 1
(Iba-1, D) and glial ﬁbrillary acidic protein (GFAP, E), respectively. Scale bar represents 50 μm. *P b 0.05 and **P b 0.01 vs. vehicle-treated cells. Adapted from [41].
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evaluatemyelination in vivo. In this context, transplantation of OPC into
the shiverer mouse brain is a well-established method employed to
evaluate not only myelination but also cell replacement in vivo. The
shiverer mouse is an autosomal recessive mutant in which there is a
large deletion in the mbp gene resulting in the failure to produce all
six classic protein isoforms of MBP, causing consequently an extensive
CNS demyelination [67]. Thus, any myelin produced by wild-type OPC
transplanted into a shiverer CNS can be unambiguously identiﬁed by
positive staining for MBP.
Other way to accelerate the evaluation of myelination in vivowill be
the designing of a transgenic mice in which myelin and neuroﬁlaments
are labeled with different ﬂuorescent markers, and that after demyelin-
ation, a genetic switch is used so that new myelin sheaths are labeled
with a third ﬂuorescent marker.
However, in vivo models when compared with in vitro and ex vivo
models are substantially more expensive and time-consuming and
force the use of a higher number of animals. Thus to test if a certain
compound is toxic ormayhave a therapeutic potential inwhat concerns
OL differentiation and myelination process, researchers must use an
in vitro model as we have described here, and only upon promising
results should they move on to the in vivo system.4. Conclusions
In vitromodels to evaluate OL development andmyelination are rel-
atively simple and useful systems for the evaluation of the cytotoxicity
of several compounds or the efﬁcacy of therapeutic strategies. Although
limited by the absence of brain circuits as well as lack of systemic circu-
lation and in vivo signaling, primary cultures are useful models that
allow the assessment of a large number of cell functions and processes.
In addition, the more complex systems described here may constitute
the ﬁrst approach to the study of the mechanisms related with changes
in myelination and some aspects of cell–cell interaction and their effect
in OL development and consequent myelination. These models also
have the crucial advantage of reducing the number of animals used in
in vivo experiments, since they allow the straightforward identiﬁcation
of the targets of different insults or disorders and the ﬁrst assay of new
proposed drugs in the same culture.Bibliography
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